Airfinity launches new COVID-19 Vaccine Supply and Production Platform

Posted on Aug 18, 2021

Airfinity's new Supply and Production Platform provides country level views of the entire COVID-19 vaccine market. This includes independent forecasts on 2021-2022 production and revenue.

Access real-time data on the number of doses that have been produced, delivered and exported for each vaccine and country. Users can also explore the different sub-suppliers for key vaccine ingredients and materials, and how this could impact future production lines.

Whether you're wanting to monitor existing supply chains, identify opportunities for commercial investment or inform global policy recommendations, Airfinity's platform provides decision makers with the tools to move faster and more efficiently.

For more information and to receive a free walkthrough of the platform, get in touch here.

More Insights From Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

Oct 10, 2022

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

Aug 25, 2022

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir

Jul 25, 2022

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market

Jul 15, 2022

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

Jul 13, 2022

Global wastage of COVID-19 vaccines could be 1.1 billion doses

Jul 11, 2022